5 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 5 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olfactory Performance in Culinary Arts Students Olfactory training - Loss of Smell, Olfactory Disorder | Phase 4 | Unknown | Leigh Sowerby | 120 | 2023-09-25 | 2023-10-06 |
| Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell. Aerosolized 13 cis retinoic acid plus Vitamin D, Aerosolized All trans retinoic acid plus Vitamin D, Standard therapy - Post COVID-19 Anosmia (Loss of Smell) | Phase 4 | Unknown | Kafrelsheikh University | 10000 | 2021-11-01 | 2021-11-11 |
| Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY). Essences and Essential Oils - Psychiatric Disorder, Benzodiazepine Withdrawal | Phase 4 | Unknown | Etablissement Public de Santé Barthélemy Durand | 50 | 2021-04-19 | 2022-10-18 |
| Anosmia and / or Ageusia and Early Corticosteroid Use Early-Dexamethasone, Late dexamethazone - Covid19, Anosmia | Phase 4 | Unknown | ClinAmygate | 300 | 2021-03-30 | 2023-09-06 |
| A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients Rasagiline, Placebo - Parkinson's Disease | Phase 4 | Unknown | The Parkinson's Institute | 36 | 2009-11-01 | 2013-12-02 |
Anosmia (5) · Anxiety Disorders (1) · COVID-19 (1) · Mental Disorders (1) · Parkinson Disease (1) · Sleep Initiation and Maintenance Disorders (1)
Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Sensation Disorders (5) · Signs and Symptoms (5) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Dyssomnias (1) · Infections (1) · Lung Diseases (1) · Movement Disorders (1)
Dexamethasone (1) · Oils, Volatile (1) · Olfactory Training (1) · Standard of Care (1) · Vitamin D (1) · rasagiline (1)
ClinAmygate (1) · Etablissement Public de Santé Barthélemy Durand (1) · Kafrelsheikh University (1) · Leigh Sowerby (1) · The Parkinson's Institute (1)
Egypt (2) · Canada (1) · China (1) · France (1) · Saudi Arabia (1) · United States (1)
Christian Trichard (1) · Emad R Issak, MD (1) · Grace S Liang, MD (1) · Mahmoud Elkazzaz, M.Sc of Biochemistry (1) · Tamer Haydara, Ass/Prof of Internal medicine (1)